Skip to content

Clinical study on reducing the malignant risk of residual lung GGN with Jiawei Xiaolong pill based on AI image judgment Technology

Clinical study on reducing the malignant risk of residual lung GGN with Jiawei Xiaolong pill based on AI image judgment Technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037554
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ground glass nodule of lung

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. lung surgery was performed, postoperative pathology was cancer, residual ground glass nodules, ground glass nodules met the diagnostic criteria of Western medicine, CT imaging showed ground glass nodules, the maximum diameter of nodules was less than 8 mm; 2. TCM syndrome differentiation belongs to liver stagnation and qi stagnation, spleen deficiency and phlegm dampness syndrome; 3. Aged 25 to 80 years old; 4. the course of oral Chinese medicine in outpatient department was more than 12 months, and informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. in the process of clinical study, some complications and complications occurred, which affected the efficacy and safety judgment; 2. the subjects had poor compliance and could not continue to cooperate to complete the 12-month course of treatment; 3. serious adverse reactions occurred and it was not suitable to continue the trial; 4. the subjects asked to withdraw from the trial; 5. For various reasons, the patient is unwilling to accept traditional Chinese medicine treatment; 6. The patients underwent the operation of ground glass nodule again.

Design outcomes

Primary

MeasureTime frame
Chest CT;

Countries

China

Contacts

Public ContactShou Weizhen

Longhua Hospital Shanghai University of Traditional Chinese Medicine

shouweizhen@sina.com+86 18917763086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026